Brendan Lee

Dr. Brendan Lee is Professor and Chairman of the Department of Molecular and Human Genetics (DMHG) at Baylor College of Medicine (BCM). Dr. Lee co-directs the Lawrence Family Bone Disease Program of Texas, and the Center for Skeletal Medicine and Biology. He is the founder and chief of the Skeletal Dysplasia Clinic at Texas Children’s Hospital, and of the Medical Student Research Pathway at BCM.

As a pediatrician and geneticist, Dr. Lee studies structural birth defects and inborn errors of metabolism. He has published over 320 peer-reviewed papers and over 85 invited reviews, chapters, and books. His work has garnered over $87M in continuous NIH funding over the past 25 years. He leads the NIH BCM Undiagnosed Diseases Network Clinical Site, NIH BCM RE-JOIN Consortium site, NIH Brittle Bone Disorders Consortium, and the NIH All of US Evenings with Genetics Scholars Program.

He holds multiple patents in therapeutics and licensed technologies are in industry-sponsored clinical development (for osteoarthritis, Osteogenesis Imperfecta, and Maple Syrup Urine Disease). He has served on advisory panels including the Advisory Committee to the Director of the NIH. Dr. Lee was previously an HHMI Investigator prior to becoming Chairman of the DMHG in 2014. The DMHG integrates basic/translational/clinical research, prenatal/pediatric/adult clinical services, and molecular pathology activities ranking first in NIH funding for the past 12 years among US medical school genetics departments.

His global engagement activities include the establishment of the Baylor College of Medicine-Chinese University of Hong Kong Center for Medical Genetics.